Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial
Meng Wang, Weiran Liu, H. Guo, Hao Long et autres
cn (code pays fourni par la source)
1 citation
Signal Transduction and Targeted Therapy